Dr Reddy's

The DRDO created 2-Deoxy-D-Glucose (2-DG) has solicited Expression of Interest for the technology to be licensed to Indian pharmaceutical businesses for production. The drug was developed by a DRDO lab- the Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr. Reddy Laboratories. Helping COVID patients for a faster recovery, the drug reduces dependency on medical oxygen. Notably, a higher number of patients treated with… read-more

The Dr. Reddy's Laboratories on May 14 rolled out the Russian COVID-19 vaccine Sputnik V in India with the first dose administered in Hyderabad. The imported vaccine under current pilot project has been priced at Rs 995.4/dose including 5% GST. Expecting second and further imported consignments in upcoming months, DRL said supply from Indian manufacturers will commence soon. DRL also hoped of probably cheaper price when local supplies begin… read-more

The Indian subject expert committee on April 12, has approved the Russian Vaccine Sputnik V for the emergency use. This approval was made during the time of vaccine shortage in various states of the country. Partnered with Russian manufacturers, Dr. Reddy’s Laboratories will receive 100 million doses of the Sputnik V vaccine as agreed. Earlier, the expert committee sought information on Sputnik V vaccine clinical trials.

The Russian Covid-19 vaccine ‘Sputnik V’ developer on December 14 reported that the vaccine has indicated more than 91.4% efficacy in the clinical trials. Reportedly, under the registered clinical trials of Sputnik V, more than 26,000 volunteers were vaccinated in Russia. In an official statement, the developers said that "No unexpected adverse events were identified as a part of the research." Moreover, In India, Sputnik V trials are being… read-more

After suffering a cyberattack recently, Indian pharmaceutical firm Dr Reddy's has disabled all its data centres. Reportedly, the company witnessed data breach at its plants in India, US, Brazil, Russia and UK. However, the drugmaker stated that the impact of the cyberattack was not severe and the services suspended will be put back on track after 24 hours. The company's shares nosedived by 4.3% following the news.